Dr Daniel Piskorz, FACC is an expert in Cardiology at National University of Rosario (Argentina). Daniel Piskorz has authored 65 publications, the most recent in 2025, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 259 (community average: 125). How the SLR is computed.

LeadR Profile

Profile validated by the expert
Dr Daniel Piskorz, FACC National University of Rosario Argentina
259 ScienceLeadR Reputation 259
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Daniel Leonardo Piskorz was born in Rosario city, Argentina, on December 14th, 1957. I am married to Alicia Susana and I am father of Ignacio, also medical doctor, and Gonzalo, systems engineer. I obtained my medical doctor degree at the Medical College of the Rosario National University, Argentina, on December 15th, 1982 and specialized in cardiology at the Rosario Emergency Hospital “Dr. Clemente Alvarez”. I was matriculated as cardiologist at Santa Fe 2nd Circumscription Medical College on November 10th, 1988 and as echocardiography specialist level three on July 4th, 1991. On October 11th, 2013, the Latin American Society of Hypertension granted me the title of Hypertension Specialist. I have been speaker at many international meetings developed in London, Rome, Milano, Sidney, Washington, Anaheim, Chicago, Barcelona, Istanbul, Kyoto and all main Latin American cities. I have published approximately 300 original papers and reviews as main author in peer review national and international indexed journals and seven books “Hypertension, epidemiology, physiology, physiopathology and treatment” on 2013, “Cardiometabolism, from physiopathology to treatment” on 2014, the second edition on 2017, third edition in 2019, fourth edition on 2022, and fifth edition in 2205, and “Acute Myocardial Infarction, from pathophysiology to treatment. Applying the evidence” in 2023. I was the 2011 – 2013 President of the Argentina Hypertension Society and 2017 President of the Argentina Cardiology Federation, and I was member of the Board of Directors of the Latin-American Hypertension Society from 2013 to 2019 and from 2022 to 2025, 2018-2020 Coordinator of the Epidemiology and Cardiovascular Prevention Council of the Interamerican Society of Cardiology, 2019 Governor of the Argentina Chapter of the American College of Cardiology, 2020 to 2024 Deputy Chair of the International Society of Hypertension America´s Regional Group. I am Elected President of the Interamerican Heart Foundation, Argentina Governor of the Interamerican Society of Hypertension and Argentina Governor of the International Society of Cardiovascular Pharmacotherapy. I am Distinguish Member of the International Society of Hypertension, Overseas Affiliated Member of the British and Irish Hypertension Society, Fellow of the American College of Cardiology, Fellow of the Interamerican Society of Cardiology and Emeritus Member of the Spanish Cardiology Society. I am Editor-in-Chief of the Argentina Federation of Cardiology Journal and Associated Editor of the American Journal of Cardiovascular Prevention. My main point of interest is hypertension and cardiovascular disease.

Organizations

Career arc: 2017 - 2025
Source: PubMed

National University of Rosario

2025 - 2025

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 65

Citations

Citations: 1 167 1st author: 21 Last author: 4 Unique author: 9


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results.
PMID 41356096 — immunization, vaccines, probability, cardiovascular diseases, vaccination, influenza, human, streptococcus pneumoniae, education, heart disease risk factors
Glob Heart20250
Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design.
PMID 40763878 — immunization, vaccines, cardiovascular diseases, vaccination, influenza, human
Arch Cardiol Mex20250
The challenges of indexing and impact factor in Latin American cardiology journals.
PMID 40445929 — cardiovascular diseases, databases, bibliographic, cardiology, research
Arch Cardiol Mex20250
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
PMID 40162642 — diabetes mellitus, kidney diseases, hemoglobins, chronic disease, incidence, cardiovascular diseases, kidney, drug-related side effects and adverse reactions, diabetes mellitus, type 2, semaglutide
N Engl J Med Top journal2025414
Racial and Gender Discrimination when Tailoring Medical Management to Hypertension Treatment in Latin America.
PMID 40168082 — bias, hypertension, economic status, cardiovascular diseases, therapeutics
Am J Hypertens20251

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
N/A 1

By status:

Completed 2
Recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP based Telecare System
NCT03206814 — hypertension, blood, essential hypertension, blood pressure, antihypertensive agents, mobile applications, therapeutics
N/ARecruiting2021

LeadR Networks

Main global connection map